|
1
|
Tiang JM, Butcher NJ and Minchin RF: Small
molecule inhibition of arylamine N-acetyltransferase Type I
inhibits proliferation and invasiveness of MDA-MB-231 breast cancer
cells. Biochem Biophys Res Commun. 393:95–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji YB and Gao SY: Arylamine
N-acetyltransferases: A new inhibitor of apoptosis in HepG2
cells. J Zhejiang Univ Sci B. 9:701–706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sugamori KS, Brenneman D, Sanchez O, Doll
MA, Hein DW, Pierce WM Jr and Grant DM: Reduced
4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in
arylamine N-acetyltransferase null mice. Cancer Lett.
318:206–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen YS, Ho CC, Cheng KC, Tyan YS, Hung
CF, Tan TW and Chung JG: Curcumin inhibited the arylamines
N-acetyltransferase activity, gene expression and DNA adduct
formation in human lung cancer cells (A549). Toxicol In Vitro.
17:323–333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen JC, Hwang JM, Chen GW, Tsou MF, Hsia
TC and Chung JG: Curcumin decreases the DNA adduct formation,
arylamines N-acetyltransferase activity and gene expression in
human colon tumor cells (colo 205). In Vivo. 17:301–309.
2003.PubMed/NCBI
|
|
6
|
Chang SH, Chen GW, Yeh CC, Hung CF, Lin SS
and Chung JG: Effects of the butylated hydroxyanisole and butylated
hydroxytoluene on the DNA adduct formation and arylamines
N-acetyltransferase activity in human colon tumor cells. Anticancer
Res. 21:1087–1093. 2001.PubMed/NCBI
|
|
7
|
Chung JG: Paeonol promotion of DNA adduct
formation and arylamines N-acetyltransferase activity in
human colon tumour cells. Food Chem Toxicol. 37:327–334. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeh CC, Chung JG, Wu HC, Li YC, Lee YM and
Hung CF: Effects of butylated hydroxyanisole and butylated
hydroxytoluene on DNA adduct formation and arylamines
N-acetyltransferase activity in PC-3 cells (human prostate
tumor) in vitro. Food Chem Toxicol. 38:977–983. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin SS, Chung JG, Lin JP, Chuang JY, Chang
WC, Wu JY and Tyan YS: Berberine inhibits arylamine
N-acetyltransferase activity and gene expression in mouse
leukemia L 1210 cells. Phytomedicine. 12:351–358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su CC, Lin JG, Chung JG and Hsieh YC:
Effect of aqueous extract of Nightshade (Solanum nigrum Linn.) on
expression of NAT1 mRNA in human gastric cancer SC-M1 cells. J Chin
Med. 14:59–67. 2003.
|
|
11
|
Su CC, Lin JG, Chung JG and Hsieh YC:
Effect of aqueous extract of Nightshade (Solanum nigrum Linn.) on
activity of NAT enzyme in human gastric cancer SC-M1 cells.
Mid-Taiwan J Med. 8:8–13. 2003.
|
|
12
|
Shen KH, Liao ACH, Hung JH, Lee WJ, Hu KC,
Lin PT, Liao RF and Chen PS: α-Solanine inhibits invasion of human
prostate cancer cell by suppressing epithelial-mesenchymal
transition and MMPs expression. Molecules. 19:11896–11914. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hasanain M, Bhattacharjee A, Pandey P,
Ashraf R, Singh N, Sharma S, Vishwakarma AL, Datta D, Mitra K and
Sarkar J: α-Solanine induces ROS-mediated autophagy through
activation of endoplasmic reticulum stress and inhibition of
Akt/mTOR pathway. Cell Death Dis. 6:e18602015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao SY, Wang QJ and Ji YB: Effect of
solanine on the membrane potential of mitochondria in
HepG2 cells and [Ca2+]i in the
cells. World J Gastroenterol. 12:3359–3367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu LT, Tsou MF, Ho CC, Chuang JY, Kuo HM
and Chung JG: Berberine inhibits arylamine
N-acetyltransferase activity and gene expression in
Salmonella typhi. Curr Microbiol. 51:255–261. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stepp MW, Mamaliga G, Doll MA, States JC
and Hein DW: Folate-dependent hydrolysis of acetyl-coenzyme A by
recombinant human and rodent arylamine N-acetyltransferases.
Biochem Biophys Rep. 3:45–50. 2015.PubMed/NCBI
|
|
17
|
Sim E, Fakis G, Laurieri N and Boukouvala
S: Arylamine N-acetyltransferases - from drug metabolism and
pharmacogenetics to identification of novel targets for
pharmacological intervention. Adv Pharmacol. 63:169–205. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cordes H, Thiel C, Aschmann HE, Baier V,
Blank LM and Kuepfer L: A physiologically based pharmacokinetic
model of isoniazid and its application in individualizing
tuberculosis chemotherapy. Antimicrob Agents Chemother.
60:6134–6145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brooke EW, Davies SG, Mulvaney AW, Pompeo
F, Sim E and Vickers RJ: An approach to identifying novel
substrates of bacterial arylamine N-acetyltransferases. Bioorg Med
Chem. 11:1227–1234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sim E, Abuhammad A and Ryan A: Arylamine
N-acetyltransferases: From drug metabolism and pharmacogenetics to
drug discovery. Br J Pharmacol. 171:2705–2725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abass KM: An investigation into the
formation of tebufenozide's toxic aromatic amine metabolites in
human in vitro hepatic microsomes. Pestic Biochem Physiol.
133:73–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lacombe L, Fradet V, Lévesque É, Pouliot
F, Larue H, Bergeron A, Hovington H, Caron A, Nguile-Makao M,
Harvey M, et al: Phase II drug-metabolizing polymorphisms and
smoking predict recurrence of non-muscle-invasive bladder cancer: A
gene-smoking interaction. Cancer Prev Res. 9:189–195. 2016.
View Article : Google Scholar
|
|
23
|
Hsia TC, Yang JH, Lin HJ, Yu CS, Yu FS and
Chung JG: Paclitaxel inhibits N-acetyltransferase activity and gene
expression in human stomach tumor cells (SC-M1). Res Commun Mol
Pathol Pharmacol. 115–116:21–38. 2004.
|
|
24
|
Runge-Morris M and Kocarek TA: Expression
of the sulfotransferase 1C family: Implications for xenobiotic
toxicity. Drug Metab Rev. 45:450–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oda Y, Zhang Y, Buchinger S, Reifferscheid
G and Yang M: Roles of human sulfotransferases in genotoxicity of
carcinogens using genetically engineered umu test strains.
Environ Mol Mutagen. 53:152–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sabbioni G: Hemoglobin adducts and urinary
metabolites of arylamines and nitroarenes. Chem Res Toxicol.
30:1733–1766. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan B, Zhong W, Deng Z, Lai C, Chu J, Jiao
G, Liu J and Zhou Q: Inhibition of prostate cancer growth by
solanine requires the suppression of cell cycle proteins and the
activation of ROS/P38 signaling pathway. Cancer Med. 5:3214–3222.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Babazadeh S, Moghaddam PA, Sabatyan A and
Sharifian F: Classification of potato tubers based on solanine
toxicant using laser induced light backscattering imaging. Comput
Electron Agric. 129:1–8. 2016. View Article : Google Scholar
|
|
29
|
Shiyong Gao ZX, Ji C and Wang H: Study of
solanine on apoptosis in HepG2 cell. J Harbin Univ Commer (Natural
Sciences Edition). 23:644–650. 2007.
|
|
30
|
Ji YB, Gao SY, Ji CF and Zou X: Induction
of apoptosis in HepG2 cells by solanine and Bcl-2 protein. J
Ethnopharmacol. 115:194–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rodrigues-Lima F, Dairou J, Busi F and
Dupret JM: Human arylamine N-acetyltransferase 1: A
drug-metabolizing enzyme and a drug target? Curr Drug Targets.
11:759–766. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Butcher NJ and Minchin RF: Arylamine
N-acetyltransferase 1: A novel drug target in cancer
development. Pharmacol Rev. 64:147–165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ragunathan N, Dairou J, Pluvinage B,
Martins M, Petit E, Janel N, Dupret JM and Rodrigues-Lima F:
Identification of the xenobiotic-metabolizing enzyme arylamine
N-acetyltransferase 1 as a new target of cisplatin in breast
cancer cells: Molecular and cellular mechanisms of inhibition. Mol
Pharmacol. 73:1761–1768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao SY and Ji YB: Effect of solanine on
N-acetyltransferase activity in HepG2 cell. Chin Tradit Herbal
Drugs. 39:1688–1691. 2008.
|
|
35
|
Dupret JM and Rodrigues-Lima F: Structure
and regulation of the drug-metabolizing enzymes arylamine
N-acetyltransferases. Curr Med Chem. 12:311–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sim E, Lack N, Wang CJ, Long H, Westwood
I, Fullam E and Kawamura A: Arylamine N-acetyltransferases:
Structural and functional implications of polymorphisms.
Toxicology. 254:170–183. 2008. View Article : Google Scholar : PubMed/NCBI
|
